Ocular Hypertension (OHT)
Symptoms, Doctors, Treatments, Advances & More

Ocular Hypertension (OHT) Overview

Save information for later
Sign Up

Learn About Ocular Hypertension (OHT)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Ocular Hypertension (OHT) Local Doctors?
Elite in Ocular Hypertension (OHT)
Ophthalmology
Elite in Ocular Hypertension (OHT)
Ophthalmology
Referral may be required

The Johns Hopkins Hospital

Baltimore, MD 
Languages Spoken:
English, Spanish, Telugu

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal. Dr. Ramulu is board certified in American Board Of Ophthalmology.

Elite in Ocular Hypertension (OHT)
Elite in Ocular Hypertension (OHT)
Referral may be required

Glaucoma Associates Of Texas - Dallas

10740 N Central Expy, Ste 300, 
Dallas, TX 
Languages Spoken:
English

Davinder Grover is an Ophthalmologist practicing medicine in Dallas, Texas. Dr. Grover is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Trabeculectomy, and Cataract Removal.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Ocular Hypertension (OHT)
Ophthalmology
Elite in Ocular Hypertension (OHT)
Ophthalmology
Referral may be required

Northwell Health Glaucoma Center At MEETH

210 East 64th Street, 6th Floor, 
New York, NY 
Languages Spoken:
English, Portuguese, Spanish
Offers Telehealth

Celso Tello is an Ophthalmologist practicing medicine in New York, New York. Dr. Tello is rated as an Elite provider by MediFind in the treatment of Ocular Hypertension (OHT). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Vitrectomy. Dr. Tello is board certified in American Board Of Ophthalmology.

What are the latest Ocular Hypertension (OHT) Clinical Trials?
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma

Summary: Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab interno (inside the eye) and ab externo (outside the eye) approach. Adverse events and intraocular pressure will be assessed. XEN63 is an investigational device for the treatment of intraocular pressure (IOP)...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective, Multicenter, Randomized Clinical Trial to Evaluate the Safety and Effectiveness of ELIOS vs Competitor in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

Summary: The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively.